In silico clinical trials: concepts and early adoptions
- PMID: 29868882
- DOI: 10.1093/bib/bby043
In silico clinical trials: concepts and early adoptions
Abstract
Innovations in information and communication technology infuse all branches of science, including life sciences. Nevertheless, healthcare is historically slow in adopting technological innovation, compared with other industrial sectors. In recent years, new approaches in modelling and simulation have started to provide important insights in biomedicine, opening the way for their potential use in the reduction, refinement and partial substitution of both animal and human experimentation. In light of this evidence, the European Parliament and the United States Congress made similar recommendations to their respective regulators to allow wider use of modelling and simulation within the regulatory process. In the context of in silico medicine, the term 'in silico clinical trials' refers to the development of patient-specific models to form virtual cohorts for testing the safety and/or efficacy of new drugs and of new medical devices. Moreover, it could be envisaged that a virtual set of patients could complement a clinical trial (reducing the number of enrolled patients and improving statistical significance), and/or advise clinical decisions. This article will review the current state of in silico clinical trials and outline directions for a full-scale adoption of patient-specific modelling and simulation in the regulatory evaluation of biomedical products. In particular, we will focus on the development of vaccine therapies, which represents, in our opinion, an ideal _target for this innovative approach.
Keywords: computational modelling; in silico clinical trials; regulatory agencies; systems biomedicine.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Advancing In Silico Clinical Trials for Regulatory Adoption and Innovation.IEEE J Biomed Health Inform. 2024 Nov 8;PP. doi: 10.1109/JBHI.2024.3486538. Online ahead of print. IEEE J Biomed Health Inform. 2024. PMID: 39514353
-
In Silico Trial Approach for Biomedical Products: A Regulatory Perspective.Comb Chem High Throughput Screen. 2022;25(12):1991-2000. doi: 10.2174/1386207325666220105150147. Comb Chem High Throughput Screen. 2022. PMID: 34986768 Review.
-
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17. Stroke. 2003. PMID: 12869717
-
Credibility of In Silico Trial Technologies-A Theoretical Framing.IEEE J Biomed Health Inform. 2020 Jan;24(1):4-13. doi: 10.1109/JBHI.2019.2949888. Epub 2019 Oct 28. IEEE J Biomed Health Inform. 2020. PMID: 31670687
-
In silico modelling of physiologic systems.Best Pract Res Clin Anaesthesiol. 2011 Dec;25(4):499-510. doi: 10.1016/j.bpa.2011.08.006. Best Pract Res Clin Anaesthesiol. 2011. PMID: 22099916 Review.
Cited by
-
Criteria for the translation of radiomics into clinically useful tests.Nat Rev Clin Oncol. 2023 Feb;20(2):69-82. doi: 10.1038/s41571-022-00707-0. Epub 2022 Nov 28. Nat Rev Clin Oncol. 2023. PMID: 36443594 Free PMC article. Review.
-
Variational Autoencoder Modular Bayesian Networks for Simulation of Heterogeneous Clinical Study Data.Front Big Data. 2020 May 28;3:16. doi: 10.3389/fdata.2020.00016. eCollection 2020. Front Big Data. 2020. PMID: 33693390 Free PMC article.
-
Synthetic data in health care: A narrative review.PLOS Digit Health. 2023 Jan 6;2(1):e0000082. doi: 10.1371/journal.pdig.0000082. eCollection 2023 Jan. PLOS Digit Health. 2023. PMID: 36812604 Free PMC article.
-
A broad look into the future of rheumatoid arthritis.Ther Adv Musculoskelet Dis. 2022 Feb 9;14:1759720X221076211. doi: 10.1177/1759720X221076211. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 35154419 Free PMC article. Review.
-
Development of scalable lymphatic system in the 4D XCAT phantom: Application to quantitative evaluation of lymphoma PET segmentations.Med Phys. 2022 Nov;49(11):6871-6884. doi: 10.1002/mp.15963. Epub 2022 Sep 18. Med Phys. 2022. PMID: 36053829 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical